Article: Factor VIII coagulant activity and factor VIII-like antigen: independent molecular entities

Factor VIII coagulant activity (VIII(C)) and the von Willebrand's disease antigen (Factor VIII-like antigen, vW-Ag) are biologically linked, and it has been suggested that they reside on the same molecule. However, insolubilized human isoantibody to VIII(C) and rabbit antiserum containing antibodies to VIII(C) and vW-Ag differentially bind and remove these entities from plasma, thus physically segregating one from the other. These findings indicate that Factor VIII coagulant activity resides on a molecule distinct from that expressing the von Willebrand's antigen.

Citing Articles

Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.

Pipe S, Montgomery R, Pratt K, Lenting P, Lillicrap D Blood. 2016; 128(16):2007-2016.

PMID: 27587878 PMC: 5073181. DOI: 10.1182/blood-2016-04-713289.

The defect in hemophilic and von Willebrand's disease plasmas studied by a recombination technique.

COOPER H, Wagner R J Clin Invest. 1974; 54(5):1093-9.

PMID: 4213756 PMC: 301657. DOI: 10.1172/JCI107853.

Direct characterization of factor VIII in plasma: detection of a mutation altering a thrombin cleavage site (arginine-372----histidine).

Arai M, Inaba H, Higuchi M, Antonarakis S, Kazazian Jr H, Fujimaki M Proc Natl Acad Sci U S A. 1989; 86(11):4277-81.

PMID: 2498882 PMC: 287434. DOI: 10.1073/pnas.86.11.4277.

ZIMMERMAN T, Roberts J, Edgington T Proc Natl Acad Sci U S A. 1975; 72(12):5121-5.

PMID: 1082139 PMC: 388888. DOI: 10.1073/pnas.72.12.5121.

Presence of factor VIII-related antigen in blood platelets of patients with Von Willebrand's disease.

Bouma B, DeGraaf S, Sixma J, van Mourik J Nature. 1975; 257(5526):510-12.

PMID: 1080838 PMC: 7086501. DOI: 10.1038/257510a0.

References

1.

Cuatrecasas P, Wilchek M, ANFINSEN C . Selective enzyme purification by affinity chromatography. Proc Natl Acad Sci U S A. 1968; 61(2):636-43. PMC: 225207. DOI: 10.1073/pnas.61.2.636. View

2.

Bennett E, Huehns E . Immunological differentiation of three types of haemophilia and identification of some female carriers. Lancet. 1970; 2(7680):956-8. DOI: 10.1016/s0140-6736(70)92129-x. View

3.

Stites D, HERSHGOLD E, Perlman J, Fudenberg H . Factor 8 detection by hemagglutination inhibition: hemophilia A and von Willebrand's disease. Science. 1971; 171(3967):196-7. DOI: 10.1126/science.171.3967.196. View

4.

ZIMMERMAN T, Ratnoff O, Powell A . Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant.... J Clin Invest. 1971; 50(1):244-54. PMC: 291913. DOI: 10.1172/JCI106480. View

5.

Bouma B, Wiegerinck Y, Sixma J, van Mourik J, MOCHTAR I . Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease. Nat New Biol. 1972; 236(65):104-6. DOI: 10.1038/newbio236104a0. View

6.

Pool J, Miller R . Assay of the immune inhibitor in classic haemophilia: application of virus-antibody reaction kinetics. Br J Haematol. 1972; 22(5):517-28. DOI: 10.1111/j.1365-2141.1972.tb05699.x. View

7.

Bennett B, Ratnoff O, Levin J . Immunologic studies in von Willebrand's disease. Evidence that the antihemophilic factor (AHF) produced after transfusions lacks an antigen associated with normal AHF and the inactive material produced by patients with classic hemophilia. J Clin Invest. 1972; 51(10):2597-601. PMC: 332958. DOI: 10.1172/JCI107077. View

8.

HOYER L . Immunologic studies of antihemophilic factor (AHF, factor VIII). IV. Radioimmunoassay of AHF antigen. J Lab Clin Med. 1972; 80(6):822-33. View

9.

Weiss H, Rogers J . Correction of the platelet abnormality in von Willebrand's disease by cryoprecipitate. Am J Med. 1972; 53(6):734-8. DOI: 10.1016/0002-9343(72)90190-8. View

10.

Holmberg L, Nilsson I . Two genetic variants of von Willebrand's disease. N Engl J Med. 1973; 288(12):595-8. DOI: 10.1056/NEJM197303222881202. View

11.

Howard M, SAWERS R, FIRKIN B . Ristocetin: a means of differentiating von Willebrand's disease into two groups. Blood. 1973; 41(5):687-90. View

12.

Meyer D, Jenkins C, Dreyfus M, LARRIEU M . Letter: Experimental model for von Willebrand's disease. Nature. 1973; 243(5405):293-4. DOI: 10.1038/243293a0. View

Factor VIII Coagulant Activity and Factor VIII-like Antigen: Independent Molecular Entities